These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 18829874

  • 21. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study.
    Wu RR, Zhao JP, Guo XF, He YQ, Fang MS, Guo WB, Chen JD, Li LH.
    Am J Psychiatry; 2008 Mar; 165(3):352-8. PubMed ID: 18245179
    [Abstract] [Full Text] [Related]

  • 22. Orally disintegrating olanzapine and potential differences in treatment-emergent weight gain.
    Karagianis J, Hoffmann VP, Arranz B, Treuer T, Maguire GA, de Haan L, Chawla B.
    Hum Psychopharmacol; 2008 Jun; 23(4):275-81. PubMed ID: 18338426
    [Abstract] [Full Text] [Related]

  • 23. Religious delusions in an evangelical Christian woman with anorexia nervosa.
    Moga DE, Cabaniss DL, Marcus ER, Walsh BT, Kahn DA.
    J Psychiatr Pract; 2009 Nov; 15(6):477-83. PubMed ID: 19934724
    [Abstract] [Full Text] [Related]

  • 24. Weight gain as a prognostic indicator of therapeutic improvement during acute treatment of schizophrenia with placebo or active antipsychotic.
    Ascher-Svanum H, Stensland MD, Kinon BJ, Tollefson GD.
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):110-7. PubMed ID: 16280344
    [Abstract] [Full Text] [Related]

  • 25. An open-label study of quetiapine in anorexia nervosa.
    Bosanac P, Kurlender S, Norman T, Hallam K, Wesnes K, Manktelow T, Burrows G.
    Hum Psychopharmacol; 2007 Jun; 22(4):223-30. PubMed ID: 17487935
    [Abstract] [Full Text] [Related]

  • 26. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
    Saddichha S, Ameen S, Akhtar S.
    J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
    [Abstract] [Full Text] [Related]

  • 27. Lessons from each drug trial.
    Marder SR.
    Am J Psychiatry; 2007 Mar; 164(3):375-6. PubMed ID: 17329457
    [No Abstract] [Full Text] [Related]

  • 28. Olanzapine in anorexia nervosa.
    Bosanac P, Burrows G, Norman T.
    Aust N Z J Psychiatry; 2003 Aug; 37(4):494. PubMed ID: 12873339
    [No Abstract] [Full Text] [Related]

  • 29. What is the scientific evidence for the use of antipsychotic medication in anorexia nervosa?
    Court A, Mulder C, Hetrick SE, Purcell R, McGorry PD.
    Eat Disord; 2008 Aug; 16(3):217-23. PubMed ID: 18443980
    [Abstract] [Full Text] [Related]

  • 30. Atypical antipsychotics and anorexia nervosa: a review.
    McKnight RF, Park RJ.
    Eur Eat Disord Rev; 2010 Jan; 18(1):10-21. PubMed ID: 20054875
    [Abstract] [Full Text] [Related]

  • 31. Atypical antipsychotics in severe anorexia nervosa in children and adolescents--review and case reports.
    Mehler-Wex C, Romanos M, Kirchheiner J, Schulze UM.
    Eur Eat Disord Rev; 2008 Mar; 16(2):100-8. PubMed ID: 18000964
    [Abstract] [Full Text] [Related]

  • 32. The pharmacologic treatment of eating disorders.
    Walsh BT, Devlin MJ.
    Psychiatr Clin North Am; 1992 Mar; 15(1):149-60. PubMed ID: 1347938
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
    Niufan G, Tohen M, Qiuqing A, Fude Y, Pope E, McElroy H, Ming L, Gaohua W, Xinbao Z, Huichun L, Liang S.
    J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327
    [Abstract] [Full Text] [Related]

  • 35. Controlled trial of zinc supplementation in anorexia nervosa.
    Birmingham CL, Goldner EM, Bakan R.
    Int J Eat Disord; 1994 Apr; 15(3):251-5. PubMed ID: 8199605
    [Abstract] [Full Text] [Related]

  • 36. Risperidone in anorexia nervosa.
    Newman-Toker J.
    J Am Acad Child Adolesc Psychiatry; 2000 Aug; 39(8):941-2. PubMed ID: 10939220
    [No Abstract] [Full Text] [Related]

  • 37. Premature termination of treatment for anorexia nervosa: differences between patient-initiated and staff-initiated discharge.
    Sly R, Mountford VA, Morgan JF, Lacey JH.
    Int J Eat Disord; 2014 Jan; 47(1):40-6. PubMed ID: 24323526
    [Abstract] [Full Text] [Related]

  • 38. Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.
    Ascher-Svanum H, Stensland M, Zhao Z, Kinon BJ.
    BMC Psychiatry; 2005 Jan 13; 5():3. PubMed ID: 15649317
    [Abstract] [Full Text] [Related]

  • 39. Pimozide combined with behavior therapy in the short-term treatment of anorexia nervosa. A double-blind placebo-controlled cross-over study.
    Vandereycken W, Pierloot R.
    Acta Psychiatr Scand; 1982 Dec 13; 66(6):445-50. PubMed ID: 6758492
    [Abstract] [Full Text] [Related]

  • 40. Olanzapine versus placebo in the treatment of adolescents with bipolar mania.
    Tohen M, Kryzhanovskaya L, Carlson G, Delbello M, Wozniak J, Kowatch R, Wagner K, Findling R, Lin D, Robertson-Plouch C, Xu W, Dittmann RW, Biederman J.
    Am J Psychiatry; 2007 Oct 13; 164(10):1547-56. PubMed ID: 17898346
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.